Enodia Therapeutics
Develops small-molecule therapies for targeted protein degradation at the point of synthesis
€20.7MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Develops small-molecule therapies for targeted protein degradation at the point of synthesis